CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 92 enrolled
Drug / intervention
Verum +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05098249
NCT05098249Phase 4Completed
CompareCT.gov

Ferric Carboxymaltose With or Without Phosphate Substitution for the Treatment of Iron Deficiency or Iron Deficiency Anemia Before Elective Surgery - the DeFICIT Trial

Donat R. Spahn·interventional·Posted Oct 28, 2021·Updated May 24, 2023

In Brief

A Phase 4 clinical trial evaluating Verum and Placebo for Anemia and 2 related conditions. Completed, enrolled 92 participants across 1 site.

Detailed Summary

This is a confirmatory trial to establish superior serum phosphate stability associated with use of Phoscap® compared with placebo as a supplement for treatment of iron deficiency or iron deficiency anemia with Ferinject® before elective surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnemia, Iron-deficiency, Hypophosphatemia
CountriesSwitzerland
CollaboratorsUniversity of Zurich

Timeline

Phase 4CompletedFinished
20222023202420252026
First PostedOct 28, 2021
Enrollment StartNov 11, 2021
Primary CompletionMay 9, 2023
Study CompletionMay 23, 2023
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 4.7 years ago

Interventions

Verumdrug

The participant takes two capsules Phoscap® (3mmol/capsule) orally three times a day over 30 days beginning the day of Ferinject administration.

Placebodrug

The participant takes wo capsules Placebo orally three times a day over 30 days beginning the day of Ferinject administration.